Emcure And Gennova To Resume mRNA Collaboration With HDT

Emcure Pharmaceuticals Ltd. and its biotech subsidiary, Gennova Biopharmaceuticals Ltd. have amicably resolved all legal disputes with HDT Bio Corp. The litigation between them, including before US courts and the arbitral tribunal in London, has...

OSE Immunotherapeutics and Boehringer Partner For First-in-class Treatments

Boehringer Ingelheim and OSE Immunotherapeutics SA announced a significant expansion of their partnership. Two new tasks to foster first-in-class treatments will be added to the continuous anti-SIRPa immune oncology programs. The first involves...

Sun Pharma Accounts Net profit of Rs 2,654.58 Crore in Q4

Sun Pharmaceutical Industries Ltd revealed a united net profit of Rs 2,654.58 crore in the final quarter ended on March 31, 2024. The organization had posted a merged net benefit of Rs 1,984.47 crore in the final quarter of the past fiscal, Sun...

WHO Nods 33 National and Regional Regulatory Authorities For Medical Products

WHO has accepted the designation of 33 national and regional regulatory agencies as WHO Listed agencies (WLAs), which can be depended on to meet the highest level of regulatory standards and practices for the quality, safety, and efficacy of drugs...

Sanofi, Formation Bio and OpenAI Declare AI Partnership For Drug Development

Sanofi, Formation Bio and OpenAI are teaming up to construct AI-powered software to speed up drug advancement and carry new medicines to patients efficiently. The three groups will unite information, programming and tuned models to foster custom...

Dr Reddy's Labs and Alvotech Ink Pact To Commercialize Denosumab Biosimilar

Dr Reddy's Labs SA has forayed into a license and supply contract with Iceland-based biotech player Alvotech for the commercialisation of AVT03, the latter’s denosumab biosimilar candidate. ATV03 is a biosimilar candidate for Prolia and Xgeva...

© 2024 India Pharma Outlook. All Rights Reserved.